Although previous studies have found high level of Cav-1 from the serum of PCa patients compared with benign prostatic hyperplasia patients56,57, further studies are needed to validate the applicability of TDEs in CRPC prognosis. Here, CAV1 is linked to benign prostatic hyperplasia.